HSDT Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-21 | 2021 | Antonella Favit-Van Pelt Chief Medical Officer | 164,849 | 0 | 0 | 56,525 | 0 | 414,431 |
| 2023-04-21 | 2022 | Antonella Favit-Van Pelt Chief Medical Officer | 357,000 | 0 | 0 | 62,475 | 13,190 | 526,206 |
| 2023-04-21 | 2021 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 183,996 | 0 | 18,024 | 68,954 | 11,385 | 1,422,057 |
| 2023-04-21 | 2022 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 351,750 | 0 | 0 | 70,350 | 12,845 | 463,463 |
| 2023-04-21 | 2021 | Dane C. Andreeff President and Chief Executive Officer | 192,235 | 0 | 15,011 | 90,052 | 7,115 | 4,146,828 |
| 2023-04-21 | 2022 | Dane C. Andreeff President and Chief Executive Officer | 367,500 | 0 | 0 | 91,875 | 9,795 | 602,736 |
| 2022-04-22 | 2021 | Antonella Favit-Van Pelt Chief Medical Officer | 164,849 | 0 | 0 | 56,525 | 0 | 414,431 |
| 2022-04-22 | 2020 | Antonella Favit-Van Pelt Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022-04-22 | 2021 | Dane C. Andreeff President and Chief Executive Officer | 192,235 | 0 | 15,011 | 90,052 | 7,115 | 4,146,828 |
| 2022-04-22 | 2020 | Dane C. Andreeff President and Chief Executive Officer | 0 | 0 | 0 | 0 | 2,500 | 22,500 |
| 2022-04-22 | 2021 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 183,996 | 0 | 18,024 | 68,954 | 11,385 | 1,422,057 |
| 2022-04-22 | 2020 | Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary | 5,000 | 0 | 0 | 0 | 0 | 5,000 |
| 2022-04-22 | 2021 | Joyce LaViscount Former Chief Financial Officer, Chief Operating Officer and Secretary | 206,250 | 0 | 38,691 | 0 | 442,150 | 727,712 |
| 2022-04-22 | 2020 | Joyce LaViscount Former Chief Financial Officer, Chief Operating Officer and Secretary | 387,080 | 0 | 17,602 | 77,396 | 1,220 | 507,638 |
| 2021-04-23 | 2020 | Jonathan Sackier Former Chief Medical Officer | 200,000 | 0 | 0 | 40,000 | 1,650 | 267,389 |
| 2021-04-23 | 2019 | Jonathan Sackier Former Chief Medical Officer | 336,553 | 0 | 0 | 0 | 0 | 798,913 |
| 2021-04-23 | 2019 | Joyce LaViscount Chief Financial Officer, Chief Operating Officer and Secretary | 381,955 | 0 | 0 | 0 | 8,371 | 1,033,031 |
| 2021-04-23 | 2020 | Joyce LaViscount Chief Financial Officer, Chief Operating Officer and Secretary | 387,080 | 0 | 17,602 | 77,396 | 1,220 | 507,638 |
| 2021-04-23 | 2019 | Philippe Deschamps Former Chief Executive Officer | 492,353 | 0 | 0 | 0 | 12,373 | 1,244,502 |
| 2021-04-23 | 2020 | Philippe Deschamps Former Chief Executive Officer | 285,339 | 0 | 0 | 0 | 501,588 | 786,927 |
| 2021-04-23 | 2019 | Dane C. Andreeff Interim President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 79,144 |
| 2021-04-23 | 2020 | Dane C. Andreeff Interim President and Chief Executive Officer | 0 | 0 | 0 | 0 | 2,500 | 22,500 |
| 2020-05-11 | 2019 | Philippe Deschamps Chief Executive Officer | 484,356 | 0 | 0 | 235,664 | 12,373 | 480,166 |
| 2020-05-11 | 2018 | Jonathan Sackier Chief Medical Officer | 318,240 | 0 | 0 | 62,400 | 0 | 988,065 |
| 2020-05-11 | 2019 | Jonathan Sackier Chief Medical Officer | 336,553 | 0 | 0 | 153,544 | 0 | 958,026 |
| 2020-05-11 | 2018 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 342,720 | 0 | 0 | 67,200 | 8,234 | 25,579 |
| 2020-05-11 | 2019 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 376,464 | 0 | 0 | 138,432 | 8,371 | 1,171,463 |
| 2020-05-11 | 2018 | Philippe Deschamps Chief Executive Officer | 424,320 | 0 | 0 | 99,840 | 13,458 | 1,258,936 |
| 2019-04-26 | 2018 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 342,720 | 0 | 0 | 138,432 | 8,234 | 1,096,811 |
| 2019-04-26 | 2018 | Philippe Deschamps Chief Executive Officer | 424,320 | 0 | 0 | 235,664 | 13,458 | 1,394,760 |
| 2019-04-26 | 2017 | Philippe Deschamps Chief Executive Officer | 411,333 | 0 | 0 | 99,840 | 17,956 | 1,697,160 |
| 2019-04-26 | 2017 | Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 325,500 | 0 | 0 | 67,200 | 12,000 | 1,339,124 |
| 2019-04-26 | 2018 | Jennifer Laux Chief Commercialization Officer | 153,333 | 0 | 0 | 48,000 | 5,267 | 1,230,800 |
| 2018-05-29 | 2017 | Philippe Deschamps Chief Executive Officer Joyce LaViscount Chief Financial Officer and Chief Operating Officer | 300,000 | 0 | 0 | 56,250 | 12,000 | 667,700 |
| 2017-05-01 | 2016 | Phillipe Deschamps Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-08-16 | 2016 | Jonathan Chief Medical | 300,000 | 0 | 0 | 0 | 0 | 300,000 |
| 2016-08-16 | 2015 | Philippe Chief Executive | 360,417 | 0 | 0 | 0 | 5,000 | 797,615 |
| 2016-08-16 | 2016 | Philippe Chief Executive | 400,000 | 120,000 | 0 | 0 | 15,000 | 535,000 |
| 2016-08-16 | 2016 | Joyce | 137,500 | 0 | 0 | 0 | 5,500 | 348,848 |
| 2016-08-16 | 2015 | Jonathan Chief Medical | 100,000 | 0 | 0 | 0 | 0 | 549,797 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
